)
Edge14 Aug 2026
Deutsche Qualität: The Story of Birkenstock
From an 18th-century German shoemaker to a global footwear brand, how Birkenstock turned an orthopedic insole into the world's most popular sandal.
Pharmaids Pharmaceuticals
Pharmaids Pharmaceuticals (524572) investor relations material
Pharmaids Pharmaceuticals Q1 26/27 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q1 26/27 earnings summary12 Aug, 2026
Executive summary
Unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, were approved and published following a board meeting on August 12, 2026.
The group operates in a single segment: Contract Research and Manufacturing Services.
Financial highlights
Standalone revenue from operations for Q1 FY27 was Rs 111.53 lakhs, down from Rs 268.89 lakhs year-over-year and Rs 1,060.25 lakhs sequentially.
Standalone net profit for Q1 FY27 was Rs 61.21 lakhs, compared to a loss of Rs 132.83 lakhs year-over-year.
Consolidated revenue from operations for Q1 FY27 was Rs 412.14 lakhs, down from Rs 2,788.24 lakhs year-over-year.
Consolidated net profit for Q1 FY27 was Rs 187.15 lakhs, compared to a loss of Rs 531.53 lakhs year-over-year.
Basic and diluted EPS for Q1 FY27 were Rs 0.61 (standalone) and Rs 0.63 (consolidated), compared to negative EPS in the prior year.
Outlook and guidance
The company will hold its 37th AGM via video conferencing, with further details to be shared.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Pharmaids Pharmaceuticals
- Revenue increased but net losses persisted; borrowings and cash reserves declined.524572
Q4 25/26 - Quarterly consolidated net loss of Rs. 264.60 lakhs on revenue of Rs. 543 lakhs; lease discontinued.524572Q3 25/26
- Losses narrowed on higher revenue, with major disinvestment and debt repayment completed.524572Q2 25/26
- Q1 FY26 saw higher losses and a pending major divestment, with no impact on current results.524572Q1 25/26
- Q2 and H1 FY25 results reflect ongoing losses and negative cash flows amid sector focus.524572Q2 24/25
- Losses persist despite higher standalone revenue; consolidated revenue declines year-over-year.524572Q1 24/25
- Revenue growth offset by higher losses and increased investments in FY25.524572Q4 24/25
- Revenue up but losses deepen; asset sale and capital moves mark strategic shift.524572Q3 24/25
Next Pharmaids Pharmaceuticals earnings date
Q2 26/2712 Nov, 2026
Pharmaids Pharmaceuticals
Next Pharmaids Pharmaceuticals earnings date
Q2 26/2712 Nov, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage